128 related articles for article (PubMed ID: 15603867)
21. Levels of plasma-soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) are correlated with disease activity in rheumatoid arthritis.
Choi ST; Kang EJ; Ha YJ; Song JS
J Rheumatol; 2012 May; 39(5):933-8. PubMed ID: 22422501
[TBL] [Abstract][Full Text] [Related]
22. Reduced mortality and CD4 cell loss among carriers of the interleukin-10 -1082G allele in a Zimbabwean cohort of HIV-1-infected adults.
Erikstrup C; Kallestrup P; Zinyama-Gutsire RB; Gomo E; Butterworth AE; Pedersen BK; Ostrowski SR; Gerstoft J; Ullum H
AIDS; 2007 Nov; 21(17):2283-91. PubMed ID: 18090276
[TBL] [Abstract][Full Text] [Related]
23. Tumour necrosis factor receptors (TNFRs) in Type 2 diabetes. Analysis of soluble plasma fractions and genetic variations of TNFR2 gene in a case-control study.
Vendrell J; Broch M; Fernandez-Real JM; Gutiérrez C; Simón I; Megia A; Gallart L; Ricart W; Richart C
Diabet Med; 2005 Apr; 22(4):387-92. PubMed ID: 15787661
[TBL] [Abstract][Full Text] [Related]
24. Interleukin 10 and tumor necrosis factor-alpha genotypes in rheumatoid arthritis--association with clinical response to glucocorticoids.
de Paz B; Alperi-López M; Ballina-García FJ; Prado C; Mozo L; Gutiérrez C; Suárez A
J Rheumatol; 2010 Mar; 37(3):503-11. PubMed ID: 20080912
[TBL] [Abstract][Full Text] [Related]
25. [Serum levels and urinary excretion of soluble receptors for tumor necrosis factor (sTNF R) in patients with primary glomerulonephritis].
Kacprzyk F
Pol Arch Med Wewn; 2002 Mar; 107(3):215-21. PubMed ID: 12107979
[TBL] [Abstract][Full Text] [Related]
26. Cytokines and heart rate variability in patients with chronic heart failure.
Straburzyńska-Migaj E; Ochotny R; Wachowiak-Baszyńska A; Straburzyńska-Lupa A; Leśniewska K; Wiktorowicz K; Cieśliński A
Kardiol Pol; 2005 Nov; 63(5):478-85; discussion 486-7. PubMed ID: 16362851
[TBL] [Abstract][Full Text] [Related]
27. [Tumor necrosis factor receptors sTNF-RI and sTNF-RII in advanced chronic heart failure].
Nowak J; Rozentryt P; Szewczyk M; Gierlotka M; Duszańska A; Szyguła B; Wojnicz R; Hawranek M; Poloński L; Zembala M
Pol Arch Med Wewn; 2002 Mar; 107(3):223-9. PubMed ID: 12107980
[TBL] [Abstract][Full Text] [Related]
28. Association of tumor necrosis factor alpha and its receptor polymorphisms with rheumatoid arthritis in female patients.
Hussein YM; Mohamed RH; Pasha HF; El-Shahawy EE; Alzahrani SS
Cell Immunol; 2011; 271(1):192-6. PubMed ID: 21777909
[TBL] [Abstract][Full Text] [Related]
29. Release of soluble tumor necrosis factor receptors from polymorphonuclear cells of breast cancer patients.
Jabłońska E; Pietruska Z
Arch Immunol Ther Exp (Warsz); 1997; 45(5-6):449-53. PubMed ID: 9437501
[TBL] [Abstract][Full Text] [Related]
30. The +1858C/T PTPN22 gene polymorphism confers genetic susceptibility to rheumatoid arthritis in Mexican population from the Western Mexico.
Torres-Carrillo NM; Ruiz-Noa Y; Martínez-Bonilla GE; Leyva-Torres SD; Torres-Carrillo N; Palafox-Sánchez CA; Navarro-Hernández RE; Rangel-Villalobos H; Oregón-Romero E; Muñoz-Valle JF
Immunol Lett; 2012 Sep; 147(1-2):41-6. PubMed ID: 22743847
[TBL] [Abstract][Full Text] [Related]
31. Association of polymorphisms of the tumour necrosis factor receptors I and II and rheumatoid arthritis.
Bayley JP; Bakker AM; Kaijzel EL; Huizinga TW; Verweij CL
Rheumatology (Oxford); 2003 Aug; 42(8):969-71. PubMed ID: 12730509
[TBL] [Abstract][Full Text] [Related]
32. Levels of soluble TNF-RII are increased in serum of patients with primary progressive multiple sclerosis.
Fissolo N; Cantó E; Vidal-Jordana A; Castilló J; Montalban X; Comabella M
J Neuroimmunol; 2014 Jun; 271(1-2):56-9. PubMed ID: 24794503
[TBL] [Abstract][Full Text] [Related]
33. Correlation of rheumatoid arthritis severity with the genetic functional variants and circulating levels of macrophage migration inhibitory factor.
Radstake TR; Sweep FC; Welsing P; Franke B; Vermeulen SH; Geurts-Moespot A; Calandra T; Donn R; van Riel PL
Arthritis Rheum; 2005 Oct; 52(10):3020-9. PubMed ID: 16200611
[TBL] [Abstract][Full Text] [Related]
34. Potential novel biomarkers of disease activity in rheumatoid arthritis patients: CXCL13, CCL23, transforming growth factor alpha, tumor necrosis factor receptor superfamily member 9, and macrophage colony-stimulating factor.
Rioja I; Hughes FJ; Sharp CH; Warnock LC; Montgomery DS; Akil M; Wilson AG; Binks MH; Dickson MC
Arthritis Rheum; 2008 Aug; 58(8):2257-67. PubMed ID: 18668547
[TBL] [Abstract][Full Text] [Related]
35. Serum levels of TNF-alpha, TNF-alphaRI, TNF-alphaRII and IL-12 in treated rheumatoid arthritis patients.
Ebrahimi AA; Noshad H; Sadreddini S; Hejazi MS; Mohammadzadeh Sadigh Y; Eshraghi Y; Ghojazadeh M
Iran J Immunol; 2009 Sep; 6(3):147-53. PubMed ID: 19801788
[TBL] [Abstract][Full Text] [Related]
36. Macrophage-inducible C-type lectin is associated with anti-cyclic citrullinated peptide antibodies-positive rheumatoid arthritis in men.
Wu XY; Guo JP; Yin FR; Lu XL; Li R; He J; Liu X; Li ZG
Chin Med J (Engl); 2012 Sep; 125(17):3115-9. PubMed ID: 22932191
[TBL] [Abstract][Full Text] [Related]
37. Tumor necrosis factor-alpha gene polymorphism in severe and mild-moderate rheumatoid arthritis.
Fabris M; Di Poi E; D'Elia A; Damante G; Sinigaglia L; Ferraccioli G
J Rheumatol; 2002 Jan; 29(1):29-33. PubMed ID: 11824966
[TBL] [Abstract][Full Text] [Related]
38. [Serum concentration and urinary excretion of soluble receptors for tumor necrosis factor in patients with primary glomerulonephritis].
Kacprzyk F
Pol Merkur Lekarski; 2003 Oct; 15(88):383-6; discussion 386-7. PubMed ID: 14974372
[TBL] [Abstract][Full Text] [Related]
39. Soluble TNF and IL-2 receptors in patients with breast cancer.
Tesarová P; Kvasnicka J; Umlaufová A; Homolková H; Jirsa M; Tesar V
Med Sci Monit; 2000; 6(4):661-7. PubMed ID: 11208388
[TBL] [Abstract][Full Text] [Related]
40. Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases 1 (TIMP-1), and MMP-1/TIMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis versus other surrogate markers.
Keyszer G; Lambiri I; Nagel R; Keysser C; Keysser M; Gromnica-Ihle E; Franz J; Burmester GR; Jung K
J Rheumatol; 1999 Feb; 26(2):251-8. PubMed ID: 9972954
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
